FHA
RARE icon

First Horizon Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

First Horizon Advisors’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$7.67K Buy
+211
New +$7.61K ﹤0.01% 1752
2022
Q3 		– Sell
-4
Closed – – 2417
2022
Q2 		$0 Buy
+4
New +$246 ﹤0.01% 2510
2022
Q1 		– Sell
-4
Closed – – 2175
2021
Q4 		$0 Buy
+4
New +$325 ﹤0.01% 2400
2020
Q3 		– Sell
-142
Closed -$11K – 1511
2020
Q2 		$11K Hold
142
– – ﹤0.01% 984
2020
Q1 		$6K Buy
+142
New +$7.37K ﹤0.01% 1081

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return